Cargando…
Pembrolizumab: Guillain Barre Syndrome: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256977/ http://dx.doi.org/10.1007/s40278-021-98518-3 |
Ejemplares similares
-
Guillain-Barre syndrome induced by pembrolizumab and sunitinib: A case report
por: Han, Chen, et al.
Publicado: (2020) -
Safe Transition to Pembrolizumab following Ipilimumab-Induced Guillain-Barré Syndrome: A Case Report and Review of the Literature
por: Gravbrot, Nicholas, et al.
Publicado: (2019) -
Bamlanivimab: Guillain-Barre syndrome: case report
Publicado: (2021) -
Tozinameran: Guillain-Barre syndrome: case report
Publicado: (2021) -
Tozinameran: Guillain-Barre syndrome: case report
Publicado: (2022)